A study to understand the effect of Niraparib in men with end-stage PCA+

Update Il y a 4 ans
Reference: EUCTR2016-002057-38

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To assess the efficacy of niraparib in subjects with measurable mCRPC and DNA-repair anomalies.


Inclusion criteria

  • mCRPC and DNA-repair anomalies